Drug Delivery Devices

Drug Delivery Devices Market Outlook

The global drug delivery devices market is projected to reach USD 1.5 billion by 2033, growing at a CAGR of approximately 7.8% during the forecast period from 2025 to 2033. This growth is primarily driven by the increasing prevalence of chronic diseases, the rising aging population, and advancements in technology that have improved the efficacy and safety of drug delivery methods. Furthermore, the growing demand for patient-centric healthcare solutions and the increasing preference for non-invasive delivery methods are propelling innovation in this sector. The global healthcare landscape is shifting towards better management of patients, and drug delivery devices play a pivotal role in this transformation, enhancing the quality of life among patients while ensuring effective medication administration.

Growth Factor of the Market

The growth of the drug delivery devices market is significantly influenced by several factors, including technological advancements, increasing healthcare expenditure, and the rising incidence of diseases that necessitate effective drug administration methods. The surge in the development of biologics and biosimilars has also created a demand for advanced drug delivery systems that can handle complex formulations. Additionally, government initiatives promoting innovations in drug delivery methods and increased funding for research and development are expected to further drive market growth. The global trend towards personalized medicine is another crucial factor, as it necessitates tailored drug delivery systems that cater to individual patient needs. Moreover, the shift from traditional hospital-based care to home healthcare settings is reshaping the market landscape, leading to an increased demand for user-friendly and efficient drug delivery devices.

Key Highlights of the Market

• The injectable drug delivery devices segment is anticipated to dominate the market due to their widespread use and effectiveness.
• North America is expected to hold the largest market share, driven by advanced healthcare infrastructure and high adoption rates of innovative technologies.
• The rise in outpatient care and home care settings is propelling the demand for portable drug delivery devices.
• Technological advancements such as microneedles and electroporation are enhancing the efficacy of drug delivery methods.
• Market players are increasingly focusing on partnerships and collaborations to enhance their product offerings and expand their market reach.

By Product Type

Injectable Drug Delivery Devices:

Injectable drug delivery devices are among the most widely used methods for administering medications. They include syringes, auto-injectors, and pen injectors, which provide a convenient way to deliver drugs, especially biologics and vaccines. The increasing prevalence of chronic conditions such as diabetes and arthritis necessitates the use of injectable devices, as they allow for precise dosing and rapid absorption into the bloodstream. Furthermore, advancements in technologies such as prefilled syringes and smart injectors are enhancing patient compliance by simplifying the injection process. As more patients prefer self-administration of medications at home, the demand for these devices is expected to grow significantly, contributing to the overall market expansion.

Implantable Drug Delivery Devices:

Implantable drug delivery devices are designed for sustained drug release and are typically used for chronic conditions that require long-term therapy. These devices can be implanted in various body tissues and deliver medication over an extended period without the need for frequent administration. The rising prevalence of conditions such as cancer, cardiovascular diseases, and neurological disorders is driving the demand for implantable devices, as they provide a more effective and convenient method of delivering drugs. Innovations in materials and design are enhancing the performance of these devices, making them safer and more reliable. The ability to administer targeted therapy with minimal systemic exposure is also a significant advantage, further solidifying their place in the drug delivery devices market.

Transdermal Drug Delivery Devices:

Transdermal drug delivery devices, such as patches and gels, offer a non-invasive method of delivering medication through the skin. This method is particularly beneficial for patients who have difficulty swallowing pills or require consistent drug levels in the bloodstream. The convenience and ease of use associated with transdermal devices are driving their popularity, particularly among patients with chronic pain or hormone-related conditions. Recent advancements in transdermal technologies, including microneedles and iontophoresis, have improved the efficacy of drug delivery through the skin, allowing for a wider range of medications to be administered effectively. As a result, this segment is expected to witness significant growth in the coming years.

Inhalation Drug Delivery Devices:

Inhalation drug delivery devices are primarily used for respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). These devices, including metered-dose inhalers (MDIs) and dry powder inhalers (DPIs), allow for the direct delivery of medication to the lungs, ensuring rapid absorption and onset of action. The increasing incidence of respiratory diseases and the growing awareness of preventive healthcare measures are driving the demand for inhalation devices. Moreover, the ongoing innovations in inhalation technologies, such as the development of smart inhalers that track usage and provide feedback, are enhancing patient adherence to prescribed therapies, further boosting market growth in this segment.

Oral Drug Delivery Devices:

Oral drug delivery devices, including tablets, capsules, and oral sprays, are among the most commonly used forms of medication administration due to their convenience and patient acceptance. The growing preference for self-medication and the availability of over-the-counter oral medications are driving the demand for this segment. Recent advancements in oral drug formulations and technologies, such as controlled-release systems and taste-masking techniques, are improving the efficacy and patient experience associated with oral medications. The oral drug delivery market is also benefiting from the increasing use of biologics that require innovative delivery methods, further propelling growth in this segment.

By Application

Hospitals:

Hospitals remain a key application area for drug delivery devices, as they are responsible for providing a wide range of healthcare services, including surgeries, emergency care, and inpatient treatment. The increasing number of surgical procedures and the growing prevalence of chronic diseases necessitate effective drug delivery systems within hospital settings. Healthcare providers require reliable devices for administering medications, particularly for complex treatments such as chemotherapy or biologic therapies. Additionally, hospitals are investing in advanced technologies to improve patient care and enhance medication safety, which further boosts the demand for innovative drug delivery devices.

Clinics:

Clinics, which include outpatient care facilities and specialized treatment centers, are experiencing an increase in the adoption of drug delivery devices due to the rising demand for convenient and effective treatment options. With the growing trend of outpatient services and the focus on preventive healthcare, clinics are increasingly utilizing drug delivery devices to enhance patient experience and improve therapeutic outcomes. Devices such as auto-injectors and inhalers are particularly popular in clinical settings, allowing for quick and efficient administration of medications. Moreover, the possibility of personalized treatment plans allows clinics to tailor drug delivery methods according to individual patient needs, thereby improving adherence and satisfaction.

Home Care Settings:

The rise of home healthcare has led to an increased demand for drug delivery devices, as patients prefer receiving treatments in the comfort of their homes. Devices such as prefilled syringes, wearable patches, and inhalers are designed for ease of use, making them ideal for self-administration. The growing aging population and the prevalence of chronic diseases that require ongoing medication management are significant factors driving this trend. Furthermore, as healthcare systems shift towards more patient-centric approaches, the emphasis on managing health at home has resulted in a surge in the development of devices that facilitate home-based therapies, ensuring patients can maintain their treatment regimens effectively.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are increasingly adopting drug delivery devices to improve patient management during and after surgical procedures. These centers focus on providing surgical services that do not require hospital admission, making efficient drug delivery vital for ensuring patient comfort and recovery. The use of injectable devices for anesthesia and pain management is prevalent in ASCs, as they allow for rapid onset and control of medication. Additionally, advancements in drug delivery technologies are enhancing the efficacy of postoperative care, allowing for better pain management and expedited recovery times. As ASCs continue to expand in response to the growing demand for outpatient surgery, the market for drug delivery devices in this sector is expected to flourish.

Others:

The "Others" segment encompasses various applications of drug delivery devices beyond hospitals, clinics, home care settings, and ambulatory surgical centers. This includes applications in research institutions, pharmaceutical companies, and even veterinary medicine. The rise in clinical trials and research activities necessitates the use of innovative drug delivery devices to test new formulations and treatment methods. Furthermore, the increasing use of drug delivery devices in veterinary practices highlights the growing recognition of their importance across different fields. As the market evolves, opportunities to explore novel applications for drug delivery devices will continue to emerge, contributing to overall market growth.

By Distribution Channel

Hospital Pharmacies:

Hospital pharmacies serve as critical distribution channels for drug delivery devices, providing medications and medical supplies to inpatient and outpatient settings. The demand for drug delivery devices in hospital pharmacies is driven by the increasing number of surgical procedures and the need for specialized medications. Hospitals often require bulk purchasing of devices to ensure a consistent supply for various treatments. Additionally, hospital pharmacies play a significant role in patient education regarding the proper use of drug delivery devices, further enhancing patient adherence to prescribed therapies. As hospitals increasingly focus on improving patient care, the role of hospital pharmacies in the drug delivery devices market will continue to grow.

Retail Pharmacies:

Retail pharmacies are vital distribution channels for drug delivery devices, providing patients with easy access to medications and over-the-counter products. The growing trend of self-medication and the increasing availability of various drug delivery devices in retail pharmacies cater to the needs of patients seeking convenience and autonomy in their treatment. Retail pharmacies often stock a wide range of drug delivery devices, including syringes, inhalers, and transdermal patches, allowing patients to choose the most suitable options for their needs. The focus on personalized customer service and patient education in retail settings further enhances the role of pharmacies in the overall drug delivery devices market, promoting better health outcomes.

Online Pharmacies:

The rise of e-commerce has transformed the landscape of pharmaceutical distribution, with online pharmacies gaining significant traction in the drug delivery devices market. The convenience of purchasing medications and devices from the comfort of one's home is driving consumers towards online platforms. Online pharmacies often offer a broader range of products, including specialized drug delivery devices, which may not be available in local retail stores. Additionally, the ability to compare prices and access customer reviews enhances the shopping experience for consumers. As the acceptance of online shopping continues to grow, particularly among younger demographics, the online pharmacy channel is expected to play an increasingly important role in the distribution of drug delivery devices.

By Technology

Electroporation:

Electroporation is a novel technology that utilizes electrical pulses to enhance the permeability of cell membranes, allowing for the efficient delivery of drugs. This technique is particularly advantageous for delivering large molecules, such as peptides and proteins, that would otherwise have difficulty penetrating biological barriers. Electroporation has gained attention in the drug delivery devices market due to its potential to improve therapeutic efficacy while minimizing side effects. The growing interest in biologics and gene therapies is further driving the demand for electroporation-based drug delivery methods, as they offer a promising solution for overcoming the limitations of traditional delivery systems. As research in this field advances, electroporation is expected to become a key player in the drug delivery technology landscape.

Sonophoresis:

Sonophoresis employs ultrasound waves to facilitate the transdermal delivery of drugs, enhancing their absorption through the skin. This non-invasive technique is particularly useful for delivering therapeutic agents that require sustained release or targeted action. The increasing focus on patient comfort and the demand for needle-free drug delivery methods are propelling the adoption of sonophoresis in the drug delivery devices market. Moreover, recent advancements in ultrasound technology and the development of portable sonophoresis devices are enhancing the feasibility of this method for home care settings, making it a promising option for patients seeking convenient medication administration.

Iontophoresis:

Iontophoresis is another innovative drug delivery technology that uses an electric field to drive charged drug molecules through the skin. This method is particularly effective for delivering small, ionizable drugs, providing targeted treatment without the need for needles. The convenience and non-invasive nature of iontophoresis make it an attractive option for patients who are apprehensive about injections. Furthermore, the ongoing advancements in iontophoresis devices, including miniaturization and user-friendly designs, are expected to enhance patient compliance and broaden the application of this technology in various therapeutic areas. As the demand for non-invasive drug delivery methods grows, iontophoresis stands to play a significant role in the market.

Microneedles:

Microneedles are tiny projections that puncture the outer layer of skin, allowing for the delivery of drugs with minimal pain and discomfort. This technology has gained significant attention due to its potential to combine the benefits of injectable and transdermal delivery methods. Microneedles can be used for a wide range of applications, including vaccines, biologics, and small-molecule drugs. Their ability to provide controlled and sustained release makes them particularly appealing for chronic disease management. As research continues to refine microneedle technology and improve its efficacy, the adoption of microneedles in the drug delivery devices market is expected to increase significantly.

By Region

The North American region holds a dominant position in the drug delivery devices market, accounting for approximately 40% of the global market share. This is primarily due to the advanced healthcare infrastructure, high prevalence of chronic diseases, and significant investment in research and development. The United States, in particular, is witnessing a rapid adoption of innovative drug delivery technologies, driven by patient-centric healthcare initiatives and increasing demand for home healthcare solutions. The market in North America is projected to grow at a CAGR of around 8.5% over the forecast period, fueled by ongoing advancements in drug delivery systems and increasing consumer awareness regarding self-administration options.

Europe holds the second-largest share in the drug delivery devices market, accounting for nearly 30% of the global market. The region is characterized by a strong emphasis on healthcare innovation and the presence of leading pharmaceutical companies that are continuously developing advanced drug delivery systems. The increasing aging population, rising prevalence of chronic diseases, and growing focus on patient-centered care are key factors driving market growth in Europe. Additionally, the adoption of digital health technologies and telemedicine is reshaping the drug delivery landscape, allowing for more personalized and efficient treatment options. As the market continues to evolve, European countries are expected to contribute significantly to the overall growth of the drug delivery devices market.

Opportunities

One of the most promising opportunities in the drug delivery devices market is the growing emphasis on personalized medicine. As healthcare shifts towards more tailored treatment approaches, there is an increasing demand for drug delivery systems that can accommodate individual patient needs. This trend presents significant opportunities for manufacturers to develop innovative devices that provide customized dosing regimens and target specific populations. Additionally, the integration of digital health technologies, such as mobile apps and telehealth platforms, is further enhancing the potential for personalized drug delivery solutions. By leveraging data analytics and patient feedback, companies can create devices that optimize therapeutic outcomes and improve patient adherence, paving the way for a more adaptive and responsive healthcare landscape.

Another opportunity lies in the expansion of drug delivery devices for biologics and biosimilars. The rising prevalence of chronic diseases, along with the increasing adoption of biologic therapies, presents a substantial market potential for devices designed specifically for these complex formulations. As the demand for biologics continues to grow, manufacturers have the opportunity to innovate and create specialized delivery systems that enhance the effectiveness and safety of these treatments. Furthermore, the ongoing advancements in technologies such as microneedles, electroporation, and other non-invasive methods are opening up new avenues for drug delivery, making it easier to administer biologics in various settings, including at home. This not only caters to patient preferences but also addresses the challenges associated with traditional delivery methods, ultimately driving market growth.

Threats

Despite the significant growth opportunities in the drug delivery devices market, there are several threats that could hinder progress. One of the primary concerns is the intense competition among manufacturers, which can lead to price wars and reduced profit margins. As more companies enter the market, particularly startups with innovative technologies, established players may face challenges in maintaining their market share. Additionally, the rapid pace of technological advancements requires continuous investment in research and development, placing financial strain on companies attempting to keep up with evolving consumer demands. Regulatory hurdles and stringent approval processes can also delay the introduction of new products, further complicating market dynamics.

Another restraining factor in the drug delivery devices market is the potential for adverse effects and complications associated with certain delivery methods. For instance, while injectable devices are widely used, they may present risks such as injection site reactions, infections, or incorrect administration. Patient concerns about pain and discomfort can lead to reluctance in embracing these devices, particularly for self-administration. Additionally, the emergence of counterfeit products poses a significant threat to patient safety and can undermine consumer confidence in the market. As the industry evolves, addressing these challenges will be essential for ensuring continued growth and acceptance of drug delivery devices.

Competitor Outlook

• BD (Becton, Dickinson and Company)
• Philips Healthcare
• Medtronic plc
• Johnson & Johnson
• Roche Diagnostics
• Abbott Laboratories
• Antares Pharma, Inc.
• Gerresheimer AG
• West Pharmaceutical Services, Inc.
• Hikma Pharmaceuticals PLC
• Stericycle, Inc.
• Teva Pharmaceutical Industries Ltd.
• Fresenius Kabi AG
• 3M Company
• GSK (GlaxoSmithKline plc)

The competitive landscape of the drug delivery devices market is characterized by a mix of established pharmaceutical companies and innovative startups. Major players are focusing on expanding their product portfolios and enhancing existing technologies to maintain a competitive edge. Strategic collaborations, mergers, and acquisitions are common tactics employed by these companies to strengthen their market positions and leverage complementary expertise. Additionally, companies are increasingly investing in research and development initiatives to drive innovation in drug delivery systems, ensuring they remain at the forefront of this rapidly evolving market.

Key players in the drug delivery devices market, such as BD and Medtronic, are renowned for their extensive experience and established product lines. BD, a leading global medical technology company, offers a wide range of drug delivery solutions, including syringes and pen injectors. Their commitment to innovation has made them a preferred choice among healthcare providers. Meanwhile, Medtronic, known for its advanced medical technologies, is continuously enhancing its drug delivery offerings, particularly in the areas of implantable devices and infusion systems, meeting the growing demands of patients and healthcare professionals alike.

Companies like Antares Pharma and Teva Pharmaceutical Industries are also making significant strides in the drug delivery devices market through their focus on specialized delivery systems. Antares Pharma is recognized for its innovative delivery methods, including autoinjectors and microneedle technology, which cater to patients' needs for ease of use and self-administration. Teva, a major player in the generic pharmaceuticals sector, is leveraging its expertise in drug formulation to develop advanced delivery systems, ensuring patients have access to effective and affordable treatments. As the market continues to evolve, these companies, along with others in the industry, will play a crucial role in shaping the future of drug delivery devices.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 3M Company
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Medtronic plc
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Gerresheimer AG
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Stericycle, Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Fresenius Kabi AG
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Johnson & Johnson
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Roche Diagnostics
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Philips Healthcare
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Abbott Laboratories
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Antares Pharma, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 GSK (GlaxoSmithKline plc)
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Hikma Pharmaceuticals PLC
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 BD (Becton, Dickinson and Company)
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 West Pharmaceutical Services, Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Teva Pharmaceutical Industries Ltd.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Drug Delivery Devices Market, By Technology
    • 6.1.1 Electroporation
    • 6.1.2 Sonophoresis
    • 6.1.3 Iontophoresis
    • 6.1.4 Microneedles
    • 6.1.5 Others
  • 6.2 Drug Delivery Devices Market, By Application
    • 6.2.1 Hospitals
    • 6.2.2 Clinics
    • 6.2.3 Home Care Settings
    • 6.2.4 Ambulatory Surgical Centers
    • 6.2.5 Others
  • 6.3 Drug Delivery Devices Market, By Product Type
    • 6.3.1 Injectable Drug Delivery Devices
    • 6.3.2 Implantable Drug Delivery Devices
    • 6.3.3 Transdermal Drug Delivery Devices
    • 6.3.4 Inhalation Drug Delivery Devices
    • 6.3.5 Oral Drug Delivery Devices
  • 6.4 Drug Delivery Devices Market, By Distribution Channel
    • 6.4.1 Hospital Pharmacies
    • 6.4.2 Retail Pharmacies
    • 6.4.3 Online Pharmacies

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Drug Delivery Devices Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Drug Delivery Devices market is categorized based on

By Product Type

• Injectable Drug Delivery Devices
• Implantable Drug Delivery Devices
• Transdermal Drug Delivery Devices
• Inhalation Drug Delivery Devices
• Oral Drug Delivery Devices

By Application

• Hospitals
• Clinics
• Home Care Settings
• Ambulatory Surgical Centers
• Others

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Technology

• Electroporation
• Sonophoresis
• Iontophoresis
• Microneedles
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• BD (Becton, Dickinson and Company)
• Philips Healthcare
• Medtronic plc
• Johnson & Johnson
• Roche Diagnostics
• Abbott Laboratories
• Antares Pharma, Inc.
• Gerresheimer AG
• West Pharmaceutical Services, Inc.
• Hikma Pharmaceuticals PLC
• Stericycle, Inc.
• Teva Pharmaceutical Industries Ltd.
• Fresenius Kabi AG
• 3M Company
• GSK (GlaxoSmithKline plc)